Invest Puerto Rico elevates the Island's role as a global bioscience R&D and manufacturing hub attracting two major life-critical investments, $228M in new activity
Share this article Share this article SAN JUAN, Puerto Rico, Feb. 3, 2021 /PRNewswire/ -- In line with its mission of promoting investment and economic development in the Island, economic development organization Invest Puerto Rico ("InvestPR"), revealed two major successes for its bioscience sector. CytoImmune Therapeutics, Inc. and Biosimilar Solutions, LLC, each committed to establishing operations on the Island to develop their biotechnology products. Invest Puerto Rico elevates the Island’s role as a global bioscience R&D and manufacturing hub attracting two major life-critical i...
Source: prnewswire.com